| dc.contributor | Ospina, María Crisitna | |
| dc.creator | Villalba Guerrero, María Camila | |
| dc.date.accessioned | 2022-07-15T23:11:14Z | |
| dc.date.accessioned | 2022-09-22T15:07:32Z | |
| dc.date.available | 2022-07-15T23:11:14Z | |
| dc.date.available | 2022-09-22T15:07:32Z | |
| dc.date.created | 2022-07-15T23:11:14Z | |
| dc.identifier | https://repository.urosario.edu.co/handle/10336/34542 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3445257 | |
| dc.description.abstract | Introduction: migraine is one of the most important primary headaches in the pediatric population; its treatment is based on acute treatment and prophylactic treatment that includes pharmacological and non-pharmacological measures. There is still no solid evidence on the effectiveness of prophylactic treatment in patients under 18 years of age and what would be the best drugs available for this population. Objective: to evaluate the effectiveness of prophylactic pharmacological treatment, compared to non-pharmacological treatment in a period of at least 3 months in patients under 18 years of age with a diagnosis of migraine. Materials and methods: systematic review of the literature that included randomized clinical trials and prospective cohort studies in patients under 18 years of age through the MEDLINE, Embase, Google Scholar, LILACS, BVS and Cochrane Database of Clinical Trials databases. , following the guidelines of the Cochrane Collaboration for systematic reviews and meta-analyses. Inclusion and exclusion criteria were established. Statistical analysis was performed using the mean difference between the variables of interest. Results: demographic aspects, pharmacological and non-pharmacological treatments, the main adverse effects of pharmacological treatments, the frequency and intensity of migraine attacks and the quality of life of the established population were characterized. Significant differences were found between the mean pre-treatment and post-pharmacological seizure frequency (p<0.001) of 7.1 seizures on average (95% CI [4.77 - 9.43]), with a pre-treatment seizure frequency of 12.3 (SD 5.22) seizures. per month versus 5.24 (SD 4.12) post-treatment crisis. Conclusions: Preventive treatment for migraine in children and adolescents can be effective. Prophylaxis is recommended for pediatric patients with migraine with or without aura. Overall data on adverse events show a favorable benefit-risk profile for the use of these therapies in the prevention of pediatric migraine. | |
| dc.language | spa | |
| dc.publisher | Universidad del Rosario | |
| dc.publisher | Maestría en Epidemiología | |
| dc.publisher | Escuela de Medicina y Ciencias de la Salud | |
| dc.rights | http://creativecommons.org/licenses/by-nc-sa/2.5/co/ | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights | Abierto (Texto Completo) | |
| dc.rights | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización.
--------------------------------------
POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos. | |
| dc.rights | Atribución-NoComercial-CompartirIgual 2.5 Colombia | |
| dc.source | Alqahtani, M., Barmherzig, R., & Lagman-Bartolome, A. M. (2021). Approach to Pediatric Intractable Migraine. Current Neurology and Neuroscience Reports, 21(8). https://doi.org/10.1007/s11910-021-01128-9 | |
| dc.source | Arias, I., De la Barrera, V., Garrido, A., Mojica, E., Polanía, M., & Villa, M. I. (2021). Banderas rojas en pacientes que consultan por cefalea: conceptos básicos y revisión narrativa de la literatura (Vol. 4, Issue 1). Universidad del Norte. | |
| dc.source | Candela, R. C., & Fernández, A. H. (2015). Cefalea en el niño y adolescente. Pediatria Integral, 19(9), 632–639. | |
| dc.source | Casasbuenas, O. (2004). Cefalea en niños. Asociación Colombiana de Neurología, 10(1), 23–33. | |
| dc.source | Cook, C. (2020). Acute Treatment of Pediatric Migraine: A Review of the Updated Guidelines. Advanced Emergency Nursing Journal, 42(1), 4–12. https://doi.org/10.1097/TME.0000000000000286 | |
| dc.source | Curcó, X. A., & Puñal, J. E. (2013). Cefalea infantil. Anales de Pediatria Continuada, 11(6), 301–311. https://doi.org/10.1016/S1696-2818(13)70152-5 | |
| dc.source | Eiland, L. S. (2007). Anticonvulsant Use for Prophylaxis of the Pediatric Migraine. Journal of Pediatric Health Care, 21(6), 392–395. https://doi.org/10.1016/j.pedhc.2007.08.006 | |
| dc.source | Evers, S., Marziniak, M., Frese, A., & Gralow, I. (2009). Placebo efficacy in childhood and adolescence migraine: An analysis of double-blind and placebo-controlled studies. Cephalalgia, 29(4), 436–444. https://doi.org/10.1111/j.1468-2982.2008.01752.x | |
| dc.source | Faria, V., Linnman, C., Lebel, A., & Borsook, D. (2014). Harnessing the placebo effect in pediatric migraine clinic. Journal of Pediatrics, 165(4), 659–665. https://doi.org/10.1016/j.jpeds.2014.06.040 | |
| dc.source | Hernández, Fabián, A., de la Vega, I. R. A., & Sánchez, H. G. (2020). Cefalea y migraña en la infancia y adolescencia. Pediatria Integral, 24(7), 393.e1-393.e17. | |
| dc.source | Hershey, A. D., Powers, S. W., Vockell, A. B., LeCates, S., Kabbouche, M. A., & Maynard, M. K. (2001). PedMIDAS: Development of a questionnaire to assess disability of migraines in children. Neurology, 57(11), 2034–2039. | |
| dc.source | Jackson, J. L., Shimeall, W., Sessums, L., DeZee, K. J., Becher, D., Diemer, M., & Berbano, E. (2010). Tricyclic antidepressants and headaches systematic reviewand meta-analysis.pdf. BMJ, 341, 1–13. | |
| dc.source | Khrizman, M., & Pakalnis, A. (2018). Management of pediatric migraine: Current therapies. Pediatric Annals, 47(2), e55–e60. https://doi.org/10.3928/19382359-20180129-02 | |
| dc.source | Lewis, D., Ashwal, S., Hershey, A., Hirtz, D., Yonker, M., & Silberstein, S. (2004). Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents [RETIRED]. In Neurology (Vol. 63, Issue 12, pp. 2215–2224). https://doi.org/10.1212/01.wnl.0000147332.41993.90 | |
| dc.source | Lewis, D. W. (2009). Pediatric Migraine. Neurologic Clinics, 27(2), 481–501. https://doi.org/10.1016/j.ncl.2008.11.003 | |
| dc.source | Loreto, M. (2014). Headaches , Assessment and Initial Management. Rev.Med.Clin.Condes, 25(4), 651–657. | |
| dc.source | Olesen, J. (2018). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202 | |
| dc.source | Oskoui, M., Pringsheim, T., Billinghurst, L., Potrebic, S., Gersz, E. M., Gloss, D., Holler-Managan, Y., Leininger, E., Licking, N., Mack, K., Powers, S. W., Sowell, M., Victorio, M. C., Yonker, M., Zanitsch, H., & Hershey, A. D. (2020). Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention. In Neurology (Vol. 94, Issue 1, pp. 50.2-50). https://doi.org/10.1212/wnl.0000000000008750 | |
| dc.source | Sampaio Rocha-Filho, P. A., & Hershey, A. D. (2017). Pediatric Migraine Disability Assessment (PedMIDAS): Translation Into Brazilian Portuguese and Cross-Cultural Adaptation. Headache, 57(9), 1409–1415. https://doi.org/10.1111/head.13159 | |
| dc.source | Santos Lasaosa, S., Rosich, P. P., Nieto, R. B., Latorre González, G., & González Oria, C. (2020). Manual de Práctica Clínica en Cefaleas. Recomendaciones. In Manual de Práctica Clínica en Cefaleas. Recomendaciones Diagnóstico- Terapéuticas de la Sociedad Española de Neurología 2020. | |
| dc.source | Sterling, T. D., Rosenbaum, W. L., & Weinkam, J. J. (1995). Publication decisions revisited: The effect of the outcome of statistical tests on the decision to publish and vice versa. American Statistician, 49(1), 108–112. https://doi.org/10.1080/00031305.1995.10476125 | |
| dc.source | instname:Universidad del Rosario | |
| dc.source | reponame:Repositorio Institucional EdocUR | |
| dc.subject | Migraña | |
| dc.subject | Tratamiento profiláctico | |
| dc.subject | Tratamiento farmacológico | |
| dc.subject | Pacientes pediátricos | |
| dc.title | Efectividad del tratamiento profiláctico farmacológico en pacientes pediátricos con migraña, una revisión sistemática | |
| dc.type | masterThesis | |
